Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue ; volume:15 ; number:1 ; day:30 ; month:1 ; year:2024 ; pages:1-14 ; date:12.2024
Nature Communications ; 15, Heft 1 (30.1.2024), 1-14, 12.2024

Creator: Shi, Guoli
Li, Tiansheng
Lai, Kin Kui
Johnson, Reed F.
Yewdell, Jonathan W.
Compton, Alex A.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-024-45075-8

URN: urn:nbn:de:101:1-2024041011422361800717

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shi, Guoli
Li, Tiansheng
Lai, Kin Kui
Johnson, Reed F.
Yewdell, Jonathan W.
Compton, Alex A.
SpringerLink (Online service)

Other Objects (12)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Omicron spike protein: a clue for viral entry and immune evasion

Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Omicron spike protein: a clue for viral entry and immune evasion

Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Omicron spike protein: a clue for viral entry and immune evasion

Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Omicron spike protein: a clue for viral entry and immune evasion

Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Omicron spike protein: a clue for viral entry and immune evasion

Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants

Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Omicron spike protein: a clue for viral entry and immune evasion

Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition

The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies

Related objects

Reset password